References
- Erdmann F, Lortet-Tieulent J, Schuz J, et al. International trends in the incidence of malignant melanoma 1953-2008–are recent generations at higher or lower risk? Int J Cancer 2013;132:385-400
- Arnold M, Holterhues C, Hollestein LM, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol 2014;28:1170-8
- Joshua AM. Melanoma prevention: are we doing enough? A Canadian perspective. Curr Oncol 2012;19:e462-7
- Holterhues C, Hollestein LM, Nijsten T, et al. Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991. Br J Dermatol 2013;169:389-7
- Song X, Zhao Z, Barber B, et al. Overall survival in patients with metastatic melanoma. Curr Med Res Opin 2015;31:987-91
- American Cancer Society. Melanoma skin cancer. 2014. http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics. Accessed March 1, 2015
- Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2012 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 (Internet). 2014. Lyon, France: International Agency for Research on Cancer, 2014
- Ekwueme DU, Guy Jr GP, Li C, et al. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006. J Am Acad Dermatol 2011;65:S133-43
- Salama AK, Rosa N, Scheri RP, et al. The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost. Cancer Invest 2012;30:637-41
- Bristow BN, Casil J, Sorvillo F, et al. Melanoma-related mortality and productivity losses in the USA, 1990–2008. Melanoma Res 2013;23:331-5
- GLOBOCAN 2008: cancer incidence, mortality and prevalence worldwide in 2008. http://globocan.iarc.fr/. Accessed March 1, 2015
- Australian Bureau of Statistics (ABS). 2012. http://www.abs.gov.au/. Accessed March 1, 2015
- Destatis: Statistiches Bundesamt. 2012. https://www.destatitis.de. Accessed March 1, 2015
- Statistics Canada. Government of Canada, Government of Canada. 2013. http://www.statcan.gc.ca/. Accessed March 1, 2015
- Instituto Brasileiro de Geografiae Estatica (IBGE). 2013. http://www.ibge.gov.br/english/. Accessed March 1, 2015
- Institut national d’etudes démographiques (INED). 2011. www.ined.fr. Accessed March 1, 2015
- ISTAT: Demografia in Cifre. 2012. http://demo.istat.it/index.html.
- Statistiska centralbyran (SCB). 2012. http://www.scb.se. Accessed March 1, 2015
- Sociedad Mexicana de demografia (SOMEDE). 2010. http://www.somede.org/. Accessed March 1, 2015
- Office for National Statistics. UK National Statistics. 2012. http://www.statistics.gov.uk/hub/index.html. Accessed March 1, 2015
- Central Intelligence Agency. The World Factbook. 2014. https://www.cia.gov/library/publications/the-world-factbook/fields/2018.html. Accessed March 1, 2015
- Instituto Nacional de Estadistica. 2011. www.ine.es. Accessed March 1, 2015
- The Department of Demography at the University of California. BUaatMPIfDRiR. The Human Life-table Database. 2007. http://www.mortality.org/ Accessed March 1, 2015
- Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48
- SEER Stat Fact Sheets: Melanoma of the Skin. 2011. http://seer.cancer.gov/statfacts/html/melan.html. Accessed March 1, 2015
- Shkolnikov VM. Methodology note on the human life-table database (HLD). 2014. http://www.lifetable.de/methodology.pdf. Accessed March 1, 2015
- Burnet NG, Jefferies SJ, Benson RJ, et al. Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds. Br J Cancer 2005;92:241-5
- Brustugun OT, Møller B and Helland Å. Years of life lost as a measure of cancer burden on a national level. Br J Cancer 2014;111:1014-20